| Literature DB >> 33449304 |
Sonja Suntrup-Krueger1,2, Paul Muhle3,4, Isabella Kampe5, Paula Egidi6, Tobias Ruck3, Frank Lenze7, Michael Jungheim8, Richard Gminski9, Bendix Labeit3,4, Inga Claus3, Tobias Warnecke3, Joachim Gross4, Rainer Dziewas3.
Abstract
Oropharyngeal dysphagia is prevalent in age-related neurological disorders presenting with impaired efficacy and safety of swallowing due to a loss of muscle force and sensory deficits. Stimulating the oropharynx with capsaicin that mediates Substance P release is an emerging pharmacological treatment option which needs further scientific evidence. Our aim was to comprehensively evaluate the effect of capsaicin on biochemical, neurophysiological, and biomechanical parameters of swallowing function. In a randomized study on healthy individuals, the impact of orally administered capsaicinoids at different dosages and application durations in comparison to non-carbonated water was evaluated. Time course and magnitude of salivary Substance P increase were monitored. Magnetoencephalography was used to detect cortical swallowing network alterations. Modifications in swallowing biomechanics were measured applying high-resolution pharyngeal manometry. Capsaicinoids at 10 μmol/L improved swallowing efficacy as seen by a significant increase of pharyngeal contractile integral and upper esophageal sphincter activation and relaxation times in manometry. Significant improvement of precision in a challenging swallow task accompanied by a reduction in swallowing-related submental electromyographic power was observed with capsaicinoids preconditioning at 10 μmol/L over 5 min, but not with continuous stimulation. The cortical activation pattern remained unchanged after any intervention. A significant increase of salivary Substance P was not detected with 10 μmol/L but with 50 μmol/L and lasted for 15 min after application. Capsaicinoids mediate dose-dependent Substance P release and positively alter swallowing biomechanics in healthy subjects. The results provide supportive evidence for the value of natural capsaicinoids to improve swallowing function.Entities:
Keywords: Capsaicin; Deglutition disorders; Dysphagia; Substance P; Swallowing
Mesh:
Substances:
Year: 2021 PMID: 33449304 PMCID: PMC8423940 DOI: 10.1007/s13311-020-00996-2
Source DB: PubMed Journal: Neurotherapeutics ISSN: 1878-7479 Impact factor: 7.620
Fig. 1Study outline
Fig. 2Time course of saliva Substance P levels according to the study intervention (baseline-normalized mean values; vertical bars indicate standard deviations; the asterisk indicates statistical significance)
High-resolution pharyngeal manometry results
| Pure water | Capsaicinoids | ||
|---|---|---|---|
| Max. velopharyngeal closing pressure, mmHg | 148.3 ± 39.3 | 146.6 ± 37.8 | 0.850 |
| Duration of velopharyngeal contraction, s | 0.71 ± 0.08 | 0.74 ± 0.07 | 0.079 |
| Max. tongue base pressure, mmHg | 242.0 ± 104.7 | 263.9 ± 132.2 | 0.279 |
| Duration of tongue base contraction, s | 0.70 ± 0.08 | 0.72 ± 0.09 | 0.138 |
| UES† max. pressures predeglutition, mmHg | 100.6 ± 42.3 | 109.7 ± 44.3 | 0.298 |
| UES† max. pressures postdeglutition, mmHg | 240.3 ± 76.4 | 253.7 ± 89.9 | 0.189 |
| UES† resting pressure, mmHg | 30.4 ± 11.4 | 32.9 ± 10.2 | 0.224 |
| UES† relaxation nadir pressure, mmHg | − 8.3 ± 4.6 | − 9.8 ± 5.4 | 0.090 |
| UES† relaxation time, s | 0.69 ± 0.07 | 0.72 ± 0.06 | 0.028* |
| UES† activation time, s | 0.87 ± 0.11 | 0.93 ± 0.07 | 0.004* |
| Pharyngeal contractile integral, mmHg cm s | 252.6 ± 148.6 | 285.7 ± 147.9 | 0.019* |
Data are given as mean ± standard deviation
*Indicates statistical significance
†Upper esophageal sphincter
MEG task performance data
| Pure water | Capsaicinoid preconditioning | Continuous capsaicinoids | ||
|---|---|---|---|---|
| Head movement (mm), mean ± SD | ||||
| Volitional swallowing | 0.35 ± 0.23 | 0.46 ± 0.39 | 0.37 ± 0.21 | 1.000 |
| Challenged swallow task | 0.22 ± 0.12 | 0.23 ± 0.14 | 0.35 ± 0.34 | 0.905 |
| Swallow count, | ||||
| Volitional swallowing | 72 ± 18 | 75 ± 30 | 71 ± 13 | 0.905 |
| Hits in challenged swallow, % ± SD | 43.2 ± 11.5 | 67.1 ± 15.9 | 46.2 ± 9.1 | < 0.0005* |
| EMG† power (μV), mean ± SD | ||||
| Volitional swallowing | 161.9 ± 178.9 | 55.0 ± 15.3 | 107.1 ± 49.6 | 0.002* |
| Challenged swallow task | 95.8 ± 41.2 | 63.2 ± 12.3 | 122.4 ± 74.9 | 0.014* |
| EMG† amplitude (μV), mean ± SD | ||||
| Volitional swallowing | 659.4 ± 440.5 | 463.4 ± 140.1 | 597.8 ± 197.4 | 0.273 |
| Challenged swallow task | 519.2 ± 145.5 | 548.2 ± 150.1 | 604.1 ± 322.6 | 0.584 |
*Indicates statistical significance in analysis of variance (ANOVA) or Friedman’s test
†Electromyographic
Fig. 3Source distribution of group-average task-related cortical activation during voluntary swallowing. Data are displayed for all three conditions and per frequency band. The color bar with negative values indicates event-related desynchronization of oscillatory activity relative to the resting stage
Fig. 4Source distribution of group-average task-related cortical activation during the challenged swallow. Data are displayed for all three conditions and per frequency band. The color bar with negative values indicates event-related desynchronization of oscillatory activity relative to the resting stage